Factors to predict unfavorable prognostic features for DFS and OS by multivariate analysis
| Survival type/variable . | Category . | Hazard ratio . | P . |
|---|---|---|---|
| DFS | |||
| Initial WBC count | ≥ 20 × 109/L | 1.49 | < .0001 |
| No. of induction therapies | 2 courses | 1.50 | .0006 |
| Age, y | > 50 | 1.33 | .0028 |
| Consolidation therapy | Multiagent CT | 1.04 | .7128 |
| OS | |||
| Age, y | > 50 | 2.00 | < .0001 |
| No. of induction therapies | 2 courses | 1.58 | .0033 |
| Initial WBC count | ≥ 20 × 109/L | 1.41 | .0070 |
| MPO-positive blast | < 50 % | 1.42 | .0149 |
| Consolidation therapy | Multiagent CT | 0.96 | .7768 |
| Survival type/variable . | Category . | Hazard ratio . | P . |
|---|---|---|---|
| DFS | |||
| Initial WBC count | ≥ 20 × 109/L | 1.49 | < .0001 |
| No. of induction therapies | 2 courses | 1.50 | .0006 |
| Age, y | > 50 | 1.33 | .0028 |
| Consolidation therapy | Multiagent CT | 1.04 | .7128 |
| OS | |||
| Age, y | > 50 | 2.00 | < .0001 |
| No. of induction therapies | 2 courses | 1.58 | .0033 |
| Initial WBC count | ≥ 20 × 109/L | 1.41 | .0070 |
| MPO-positive blast | < 50 % | 1.42 | .0149 |
| Consolidation therapy | Multiagent CT | 0.96 | .7768 |
MPO indicates myeloperoxidase.